ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE Drug Patent Profile
✉ Email this page to a colleague
When do Orphenadrine Citrate, Aspirin, And Caffeine patents expire, and what generic alternatives are available?
Orphenadrine Citrate, Aspirin, And Caffeine is a drug marketed by Sandoz and Stevens J and is included in two NDAs.
The generic ingredient in ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE is aspirin; caffeine; orphenadrine citrate. There are twenty-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the aspirin; caffeine; orphenadrine citrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE?
- What are the global sales for ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE?
- What is Average Wholesale Price for ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE?
Summary for ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
DailyMed Link: | ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE at DailyMed |